BIBLIOGRAFIA
1. Scott D.L., Wolfe F., Hulzinga T.W.J.: Rheumatoid Arthritis. The Lancet 2010, 376:1094- 1108.
2. Bijlsma J.W.J., Burmester G.R., da Silva J.A.P., Faarvang K.L., Hachulla E., Mariette X.: Eular Compendium on Rheumatic Diseases, BMJ Publishing Group Ltd, London, 2009, 61- 70.
3. Abbas A.K., Lichtman A., Pober J.S.: Immunologia cellulare e molecolare, 2a edizione, Piccin Nuova Libraria S.p.a, Padova, 1994.
4. Loza M.J., McCall C.E., Li L., Isaacs W.B., Xu J., et al.: Assembly of Inflammation-Related Genes for Pathway-Focused Genetic Analysis. PLoS ONE 2007, 2:15-16.
5. Drammis C.: La terapia riabilitativa migliora l’outcome del paziente affetto da Artrite Reumatoide in terapia con inibitori del TNF- alfa. Tesi del Dottorato di ricerca in Fisiopatologia clinica e medicina sperimentale, indirizzo in scienze reumatologiche-XIX ciclo; Università degli Studi di Napoli Federico II.
6. Boissier M.C.: Cell and cytokine imbalances in rheumatoid synovitis. Joint Bone Spine 2010, in corso di stampa. doi:10.1016/j.jbspin.2010.08.017
7. Tran C.N., Lundy S.K., Fox D.A.: Synovial biology and T cells in rheumatoid arthritis. Pathophysiology 2005, 12:183-189.
8. Lundy S.K., Sarkar S., Tesmer L.A., Fox D.A.: Cells of the synovium in rheumathoid arthritis- T lymphocytes. Arthritis Research & Therapy 2007, 9: 202.
9. Noss E.H., Brenner M.B.: The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis. Immunological Reviews 2008, 253:252-270.
11. Schett G.: Cells of the synovium in rheumatoid arthritis. Osteoclasts. Arthritis Research & Therapy 2007, 9:203.
12. Aubin J.E., Bonnelye E.: Osteoprotegerin and its Ligand: A New Paradigm for Regulation of Osteoclastogenesis and Bone Resorption. http://www.medscape.com/viewarticle/408911
13. Maruotti N., Grano M., Colucci S., D’Onofrio F., Cantatore F.P.: Osteoclastogenesis and arthritis. Clin. Exp. Med, 2010, in corso di stampa. doi: 10.1007/s10238-010-0117-2.
14. McInnes I. B., Schett G.: Cytokines in the pathogenesis of rheumatoid arthritis. Nature Reviews Immunology 2007, 7: 429-442.
15. Otero M., Goldring M.B.: Cells of the synovium in rheumatoid arthritis. Chondrocytes. Arthritis Research & Therapy 2007, 9:220.
16. Goldring Mary B., Marcu Kenneth B.: Cartilage homeostasis in health and rheumatic diseases. Arthritis Research & Therapy 2009, 11:224.
17. Mobasheri A., Bondy C.A., Moley K., Ferreira Mendes A., Carvalho R. S., Richardson S.M., Hoyland J.A., Barrett-Jolley R., Shakibaei M.: Expression, Distribution and Functional Regulation of GLUT Isoforms by Hypoxia, Hypoxia Mimetics, Growth Factors and Pro-Inflammatory Cytokines “Advances in Anatomy, Embryology and Cell Biology” , Springer-Verlag Berlin and Heidelberg GmbH & Co. K, Berlin, 2008.
18. Mueckler M.: Facilitative glucose transporters. Eur. J. Biochem. 1994, 219:713-725.
19. Anzillotti C., Pratesi F., Tommasi C., Migliorini P.: Peptidylarginine deiminase 4 and citrullination in health and disease. Autoimmunity Reviews 2010,
20. Karsdal M.A., Henriksen K., Leeming D.J., Woodworth T., Vassiliadis E., Bay-Jensen A.C.: Novel combinations of Post-Translational Modification (PTM) neo-epitopes provide tissue-specific biochemical markers- are they the cause or the consequence of the disease?. Clinical Biochemistry 2010, 43: 793-804.
21. György B., Tόth E., Tarcsa E., Falus A., Buzás E.I.: Citrullination: A posttranslational modification in health and disease. The International Journal Of Biochemistry & Cell biology 2006, 38:1662-1667.
22. Uysal H., Nandakumar K. S., Kessel C., Haag S., Carlsen S., Burkhardt H., Holmdahl R.: Antibodies to citrullinated proteins: molecular interactions and arthritogenicity. Immunological Reviews 2010, 233: 9-33.
23. Valesini G., Alessandri C.: Anticitrullinated protein/peptide antibodies and rheumatoid factors: two distinct autoantibody systems. Arthritis Research & Therapy 2009, 11:125.
24. Song Y.W., Kang E.H.: Autoantibodies in rheumatoid arthritis: rheumatoid factors and citrullinated protein antibodies. Q J Med 2010, 103: 139-146.
25. Arita K., Shimizu T., Hashimoto H., Hidaka Y., Yamada M., Sato M.: Structural basis for histone N-terminal recognition by human peptidylarginine deiminase 4. PNAS 2006, 103:5291-5296.
26. Schellekens Gerard A., de Jong Ben A.W., van den Hoogen Frank H.J., van de Putte Leo B.A.: Citrulline is an essential constituent of antigenic determinants recognised by rheumatoid arthritis-specific autoantibodies. J. Clin. Invest. 1998, 101:273- 281.
27. Gregersen P.K., Silver J., Winchester R.J..: The shared epitope hypothesis. An
approach to understanding the molecolar genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987, 30:1205-13.
28. Van der Helm- van Mil Annette H.M., Huizinga Tom W.J.: Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subset. Arthritis Research & Therapy 2008, 10:205.
29. Chujo S., Okamoto S., Sunahara R., Adachi M., Yamada K., Hayashi H., Takii T., Hayakawa K., Onozaki K.: Cigarette smoke condensate extracts augment collagen- induced arthritis in mice. Imternational Immunopharmacology 2010, 10:1194- 1199.
30. Wang Y., Li M., Stadler S., Correll S., Li P., Wang D., Hayama R., Leonelli L., Han H., Grigoryev S.A., David Allis C., Coonrod S.A.: Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. The Journal Of Cell Biology 2009, 184: 205-213.
31. Papayannopulos V., Zychlinsky A.: NETs: a new strategy for using old weapons. Trends in Immunology 2009, 130:513-521.
32. Toes Rene E.M., Huizinga T.W. J.: Autoimmune responses in the rheumatoid synovium. PLoS Medicine 2009, 6:15-16.
33. Zhao J., Liu X., Wang Z., Liu R., Li Z.: Is it necessary to combine detection of anticitrullinated protein antibodies in the diagnosis of rheumatoid arthritis?. The Journal of Rheumatology 2010, 37:12.
34. Bläss S., Specker C., Lakomek H.J., Schneider E.M. E Schwchau M.: Novel 68 Kda autoantigen detected by rheumatoid arthritis specific antibodies. Ann Rheum Dis 1995, 54:355-360
35. Young B.J., Mallya R.K., Leslie R.D., Clark C.J., Hamblin T.J..: Antikeratin antibodies in rheumatoid arthritis. Br Med J. 1979, 2: 97-99.
36. Schellekens G.A., Visser H., de Jong B.A.W., van den Hoogen F.H.J., et al. : The diagnostic properties of rheumatoid arthritis antibodies
37. Nielen M.N.., van Schaardenburg D., Reesink H.W. et al.: Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum. 2004, 50: 380-386.
38. Robinson E., Keystone E.C., Schall T.L., Gillett N., Fish E.N.: Chemokine expression in rheumatoid arthritis (RA): evidence of RANTES and macrophage inflammatory protein (MIP)-1 beta production by synovial T cells. Clin Exp Immunol 1995, 101:398-407.
39. Vander Cruyssen B., Peene I., Cantaert T., Hoffman I.E.A., De Rycke L., Veys E.M., De Keyser F.: Anti- citrullinated protein/peptide antibodies (ACPA) in rheumatoid arthritis: Specificity and relation with rheumatoid factor. Autoimmunity Reviews 2005, 4: 468– 474.
40. Cuthbert Graeme L., Daujat S., Snowden A.W., Erdjument-Bromage H., Hagiwara T., Yamada M., Schneider R., Gregory P.D., Tempst P., Bannister A. J., Kouzarides T.: Histone Deimination Antagonizes Arginine Methylation. Cell 2004, 118:545–553.
41. Walther J., Van Venrooij W.J., van Beers J.J.B.C., Pruijn Ger J.M.: Anti-CCP antibody, a marker for the early detection of rheumatoid arthritis. Ann. N.Y. Acad. Sci. 2008, 1143: 268-285.
42. Sebbag M., Chapuy-Regaud S., Auger I., Petit-Texeira E., Clavel C., Nogueira L., Vincent C., Cornélis F., Roudier J., Serre G.: Clinical and pathophysiological significance of the autoimmune response to citrullinated proteins in Rheumatoid arthritis. Joint Bone Spine 2004, 71: 493-502.
43. Wegner N., Lundberg K., Kinloch A., et al.: Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunol Rev 2009, 233: 34-54.
44. Rosengren S., Boyle D.L., Firestein G.S..: Acquisition, culture, and phenotyping of synovial fibroblast. Methods Mol Med 2007, 135:365-375.
45. Kiener H.P., Brenner M.B.: Building the synovium: cadherin-11 mediates fibroblast-like synoviocyte cell-to-cell adhesion. Arthritis Res Ther 2005, 7:49-54.
46. Firestein G.S.: Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors?. Arthritis Rheum 1996, 39:1781-1790.
47. Lafyatis R., Remmers E.F., Robets A.B., Yocum D.E., Sporn M.B., Wilder R.L.: Anchorage-independent growth of synoviocytes from arthritic and normal joints. Stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-beta and retinoids. J Clin Invest 1989, 83:1267-1276.
48. Imamura F., Aono H., Hasunuma T., Sumida T., Tateishi H., Maruo S., Nishioka K.: Monoclonal expansion of synoviocytes in rheumatoid arthritis. Arthritis Rheum 1998, 41:1979-1986.
49. Hitchon C.A., El-Gabalawy H.S.: Oxidation in rheumatoid arthritis. Arthritis Res Ther 2004, 6:265-278.
50. Naughton D.P., Haywood R., Blake D.R., Edmonds S., Hawkes G.E., Grootveld M.: A comparative evaluation of the metabolic profiles of normal and inflammatory knee joint synovial fluids by high resolution proton NMR spectroscopy. FEBS Lett 1993, 332:221-225.
51. D’Angio C.T., Finkelstein J.N.: Oxygen regulation of gene expression: a study in opposites. Mol Genet Metab 2000, 71:371-380.
52. BIAcore sensor surface Handbook BR-100571 Edition AB
53. “The SPR Pages” http://home.hccnet.nl/ja.marquart/
55. Tam J.P.: Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system. Proc Natl Acad Sci U S A 1988; 85:5409–5413.
56. Lu M.C., Lai N.S., Yu H.C., Huang H.B., Hsieh S.C., Yu C.L..: Anti-citrullinated protein antibodies bind surface-expressed Anti-citrullinated Grp78 on monocyte/macrophages and stimulate tumor necrosis factor alpha production. Arthritis Rheum. 2010, 62:1213-23.
57. Zhao X., Okeke N.L., Sharpe O., Batliwalla F.M., Lee A.T., Ho P.P., Tomooka B.H., Gregersen P.K., Robinson W.H..: Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis. Arthritis Res Ther. 2008, 10:94.
58. Pratesi F., Tommasi C., Anzillotti C., Chimenti D., Migliorini P.: Deiminated Epstein-Barr virus nuclear antigen 1 is a target of anti-citrullinated protein antibodies in rheumatoid arthritis. Arthritis Rheum. 2006, 54:733-41.
59. Anzilotti C., Merlini G., Pratesi F., Tommasi C., Chimenti D., Migliorini P.: Antibodies to viral citrullinated peptide in rheumatoid arthritis. J Rheumatol. 2006, 33:647-51.
60. Anzilotti C., Riente L., Pratesi F., Chimenti D., Delle Sedie A., Bombardieri S., Migliorini P.: IgG, IgA, IgM antibodies to a viral citrullinated peptide in patients affected by rheumatoid arthritis, chronic arthritides and connective tissue disorders. Rheumatology 2007, 46:1579-1582.
61. Pratesi F., Tommasi C., Anzilotti C., Puxeddu I., Sardano E., Di Colo G., Migliorini P.: Antibodies to a new viral citrullinated peptide, VCP2: fine specificity and relation with anti-CCP and anti-VCP1. Dati non pubblicati.
62. Sebbag M., Moinard N., Auger I., Clavel C., Arnaud J., Nogueira L., Roudier J., Serre G.: Epitopes of human fibrin recognised by the rheumatoid arthritis specific autoantibodies to citrullinated proteins. Eur J Immunol. 2006, 36:2250-2263.
63. Ioan-Facsinay A., El-Bannoudi H., Scherer H.U., van der Woude D., Ménard H.A., Lora M., Trouw L.A., Huizinga T.W., Toes R.E.: Anti-cyclic citrullinated peptide antibodies are a collection of anti-citrullinated protein antibodies and contain overlapping and non-overlapping reactivities. Ann Rheum Dis. 2011, 70:188-193.
64. Hagiwara T., Nakashima K., Hirano H., Senshu T., Yamada M.: Deimination of Arginine Residues in Nucleophosmin/B23 and Histones in HL-60 Granulocytes; Biochem Biophys Res Commun. 2002, 290: 979-983.
65. Neeli I., Khan S.N., Radic M.: Histone deimination as a response to inflammatory stimuli in neutrophils. J Immunol. 2008, 180:1895-1902.
66. Lioté F., Champy R., Moenner M., Boval-Boizard Badet J.: Elevated angiogenin levels in synovial fluid from patients with inflammatory arthritis and secretion of angiogenina by cultured synovial fibroblast. Clin Exp Immunol 2003, 132:163-168.
67. Chen M., Kallenberg C.G.: ANCA-associated vasculitides--advances in pathogenesis and treatment. Nat Rev Rheumatol. 2010, 6:653-664.
68. Fineschi S., Goffin L., Rezzonico R., Cozzi F., Dayer J.D., Meroni P.L., Chizzolini C.: Antifibroblast antibodies in sistemic sclerosis induce fibroblast to produce profibrotic chemokines, with partial exploitation of Toll-like Receptor 4. Arthritis Rheum. 2008, 58:3913-3923.
